Actively Recruiting

Age: 18Years +
All Genders
ID06669520

Correlation of Blood Serum Renalase and Microcirculation Obstruction in Patients with Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention

Led by The Third Xiangya Hospital of Central South University · Updated on 2024-11-01

200

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are exploring the connection between blood serum renalase levels and microcirculation obstruction in patients who have experienced an acute myocardial infarction (AMI) and undergone primary percutaneous coronary intervention (PCI). The goal is to identify possible risk factors for microcirculation obstruction in these patients. This observational study is sponsored by The Third Xiangya Hospital of Central South University and focuses on acute heart attack patients treated with emergency PCI. Participants must have had a STEMI heart attack within 12 hours or between 12 to 48 hours if persistent ischemic symptoms, hemodynamic instability, or life-threatening ventricular arrhythmias are present. High-risk NSTEMI patients undergoing emergency PCI may also be included. The study involves observing patients after their PCI treatment without introducing new interventions. During the study, researchers will monitor participants using contrast-enhanced magnetic resonance imaging (MRI) conducted 3 to 7 days after PCI to assess microvascular obstruction. The study will track the number of patients showing this condition. Participants will provide consent and be followed to collect data relevant to renalase levels and heart microcirculation. The total study period extends until October 2025, starting from August 2024.

CONDITIONS

Brief Title

Correlation of Blood Serum Renalase and Microcirculation Obstruction in Patients with Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • STEMI symptom onset less than 12 hours
  • STEMI symptom onset 12-48 hours with persistent ischemic symptoms, hemodynamic instability, or life-threatening ventricular arrhythmias
  • High-risk NSTEMI
  • Emergency PCI
  • Voluntary informed consent
Not Eligible

You will not qualify if you...

  • Non-obstructive acute myocardial infarction
  • Severe chronic kidney disease (estimated glomerular filtration rate less than 20 mL/min per 1.73 m²)
  • Life expectancy less than 1 year
  • Pregnant or planning to become pregnant
  • Emergency PCI failure

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Diagnostic Evaluation

Duration - 3 to 7 days after primary percutaneous coronary intervention

Participants undergo contrast-enhanced magnetic resonance imaging to assess microvascular obstruction.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

The Third Xiangya Hospital of Central South University

Changsha, Hunan, China, 410013

Actively Recruiting

Loading map...

Research Team

W

Weihong Jiang

Y

Ye Chen

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

A Danish Study to Assess the Efficacy of Implantable Cardiov...

Coronary Artery Disease

Actively Recruiting

1 location

A Multicentre Observational Study to Assess Long-term Outcom...

Acute Myocardial Infarction

Actively Recruiting

10 locations

Abbott Vascular Medical Device Registry

Acute Myocardial Infarction

Actively Recruiting

37 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Association between periprocedural change in serum renalase and microvascular obstruction in patients with STEMI after primary percutaneous coronary intervention: protocol for the ReMVOS prospective cohort study.

Ye Chen, Ruixuan Li, Ru Fu...

https://pubmed.ncbi.nlm.nih.gov/41314850